News Roundup | Johnson & Johnson Single-Dose Vaccine Authorized for Emergency Use
Article 1 Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study: Johnson & Johnson, announced that the…
Tag: Janssen
Johnson and Johnson Single-Dose Vaccine Authorized for Emergency Use Thanks to the Results of the ENSEMBLE Study
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its…
EMA Receives Application for Conditional Marketing Authorization of COVID-19 Vaccine Janssen
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by Janssen-Cilag International N.V. EMA’s human medicines committee (CHMP) will assess the…
ENSEMBLE Study Produces Positive Results as Johnson & Johnson Prepares to Submit Emergency Use Authorization for COVID-19 Vaccine Candidate
The large Phase 3 ENSEMBLE clinical trial sponsored by Johnson & Johnson (NYSE: JNJ) demonstrates topline efficacy and safety data for the investigational single-dose COVID-19…
BARDA-Supported Johnson & Johnson Unit Janssen COVID-19 Vaccine Candidate Gets Closer: Requiring Only 1 Dose & Potential EUA Request May Occur by Feb
TrialSite predicted months ago that the vaccine, sponsored by the world’s largest pharmaceutical company by revenue–Johnson & Johnson, could become the most prominent of COVID-19…
St. Jude Children’s Research Hospital & Univ. of TN Health & Science Center Recruit Volunteers for ENSEMBLE Trial: COVID-19 Vaccine from Janssen
St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center (UTHSC) now offer a testing site for the Janssen Pharmaceutical Companies of…
Emory University Conducts Yet Another Advanced State Trial Targeting COVID-19 Vaccine
Emory University has taken on another major COVID-19 vaccine trial, this time the Phase 3 trial sponsored by the Janssen Pharmaceutical Companies of Johnson &…
J&J’s COVID-19 Vaccine Temporarily Paused as Study Participant Falls Ill
Johnson & Johnson has temporarily paused its Phase 3 ENSEMBLE trial due to an unexplained illness in a study participant. This means that the company’s…
CTI Trial Site Doses First Subjects for Phase 3 J&J ENSEMBLE COVID-19 Vaccine Trial While Winning Top CRO Award: CTI On the Move
Last week, a globally active, privately held, mid-sized contract research organization (CRO) claims its research site is the very first one to dose a subject…
UC San Diego Brings J&J COVID-19 Vaccine Trial to the Southern Districts of the County to Connect with more At-Risk & Minority Groups
UC San Diego Health has joined the third major Phase 3 clinical trial assessing the efficacy and safety of a COVID-19 vaccine candidate. Now they…